HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kayoko Hayakawa Selected Research

Cefmetazole (Cefmetazole Sodium)

3/2022Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function.
11/2021Retrospective evaluation of appropriate dosing of cefmetazole for invasive urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kayoko Hayakawa Research Topics

Disease

23Infections
04/2022 - 09/2011
16COVID-19
10/2022 - 06/2020
6Sepsis (Septicemia)
08/2021 - 04/2012
6Bacteremia
01/2019 - 05/2012
4Urinary Tract Infections (Urinary Tract Infection)
03/2022 - 08/2013
4Fever (Fevers)
12/2020 - 03/2015
3Pneumonia (Pneumonitis)
01/2021 - 01/2014
3Malaria
12/2014 - 03/2014
2Critical Illness (Critically Ill)
08/2020 - 06/2015
2Candidemia
01/2019 - 01/2016
2Dengue (Dengue Fever)
03/2016 - 03/2014
2Typhoid Fever (Typhoid)
01/2016 - 07/2014
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
06/2015 - 01/2013
2Body Weight (Weight, Body)
06/2015 - 07/2014
2Wounds and Injuries (Trauma)
12/2013 - 09/2013
1Abscess
05/2022
1Aphasia (Dysphasia)
05/2022
1Hemiplegia (Spastic Hemiplegia)
05/2022
1Dyspnea (Shortness of Breath)
03/2022
1Hypoxia (Hypoxemia)
03/2022
1Collagen Diseases (Collagen Disease)
02/2022
1Neoplasms (Cancer)
02/2022
1Hypertension (High Blood Pressure)
11/2021
1Thrombosis (Thrombus)
11/2021
1Obesity
11/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2021
1Pain (Aches)
02/2021
1Leukemia
02/2021
1Mucormycosis
02/2021
1Pseudomyxoma Peritonei
12/2020
1Atopic Dermatitis (Atopic Eczema)
12/2020
1Escherichia coli Infections
09/2020
1Surgical Wound Infection
05/2020
1Cross Infection (Nosocomial Infection)
04/2020
1Rabies (Hydrophobia)
12/2019
1Back Pain (Backache)
06/2019
1Inflammation (Inflammations)
06/2019
1Arthritis (Polyarthritis)
06/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019

Drug/Important Bio-Agent (IBA)

8VancomycinFDA LinkGeneric
03/2017 - 05/2012
7Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 01/2016
5FluoroquinolonesIBA
01/2021 - 01/2013
4Pharmaceutical PreparationsIBA
06/2022 - 01/2015
4Carbapenems (Carbapenem Antibiotics)IBA
07/2017 - 04/2012
4DaptomycinFDA Link
04/2016 - 12/2012
3remdesivirIBA
05/2022 - 01/2021
3Oxygen (Dioxygen)IBA
05/2022 - 01/2019
3beta-Lactamases (beta-Lactamase)IBA
09/2020 - 02/2017
3Linezolid (Zyvox)FDA Link
07/2014 - 12/2012
3Cephalosporins (Cephalosporin Antibiotics)IBA
12/2013 - 01/2013
2Cefmetazole (Cefmetazole Sodium)FDA Link
03/2022 - 11/2021
2Indicators and Reagents (Reagents)IBA
03/2022 - 08/2021
2AnticoagulantsIBA
11/2021 - 10/2021
2CytokinesIBA
01/2021 - 08/2020
2Inosine Monophosphate (IMP)IBA
01/2021 - 01/2020
2AminoglycosidesIBA
01/2021 - 12/2013
2Clindamycin (Cleocin)FDA LinkGeneric
09/2017 - 03/2012
2Ampicillin (Omnipen)FDA LinkGeneric
09/2017 - 03/2017
2EnzymesIBA
03/2017 - 01/2014
2Immunoglobulin M (IgM)IBA
02/2017 - 03/2016
2Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2017 - 01/2016
2Penicillins (Penicillin)FDA Link
01/2017 - 12/2013
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 03/2015
2CreatinineIBA
06/2015 - 03/2015
2Colistin (Coly-Mycin)FDA Link
06/2015 - 12/2012
2C-Reactive ProteinIBA
03/2015 - 03/2014
1Angiotensin Receptor AntagonistsIBA
10/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2022
1favipiravirIBA
06/2022
1mRNA VaccinesIBA
04/2022
1flomoxefIBA
03/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2022
1Interferon LambdaIBA
01/2022
1fibrin fragment D (D-dimer)IBA
11/2021
1Explosive Agents (Explosives)IBA
09/2021
1Antiviral Agents (Antivirals)IBA
04/2021
1Terbinafine (Lamisil)FDA LinkGeneric
02/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1ChemokinesIBA
01/2021
1Fatty Acid-Binding ProteinsIBA
08/2020
1Biomarkers (Surrogate Marker)IBA
08/2020
1LopinavirFDA Link
06/2020
1Heparin (Liquaemin)FDA LinkGeneric
06/2020
1Ritonavir (Norvir)FDA Link
06/2020
1Immunoglobulins (Immunoglobulin)IBA
12/2019
1Rabies Vaccines (Rabies Vaccine)FDA Link
12/2019
1Calcium PyrophosphateIBA
06/2019
1Anti-Infective Agents (Microbicides)IBA
06/2019

Therapy/Procedure

11Therapeutics
11/2021 - 09/2011
5Drug Therapy (Chemotherapy)
02/2022 - 11/2014
2Personal Protective Equipment
01/2022 - 01/2021
2Artificial Respiration (Mechanical Ventilation)
01/2021 - 06/2020
2Extracorporeal Membrane Oxygenation
01/2021 - 06/2020
2Catheters
05/2020 - 11/2017
2Urinary Catheters
01/2019 - 08/2013
1Long-Term Care
04/2022
1Stethoscopes
12/2020
1Parenteral Nutrition
12/2020
1Stents
06/2019